Extrawell Pharmaceutical Holdings Limited (0858.HK)
HKD 0.05
(2.04%)
HKD 0.05
(2.04%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.68 Million | 3.21 Million | -1.59 Million | -232 Thousand | -10.25 Million | -15.08 Million |
| Net Income | -159.5 Million | 129.26 Million | 130.58 Million | -121.09 Million | 83.28 Million | 64.03 Million |
| Depreciation & Amortization | 9.04 Million | 8.66 Million | 8.63 Million | 8.06 Million | 6.3 Million | 6.29 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6.47 Million | 3.32 Million | 2.18 Million | 1.07 Million | -13.98 Million | 1.48 Million |
| Other non-cash items | 13.01 Million | -138.04 Million | -143 Million | 111.72 Million | -85.85 Million | -86.9 Million |
| Investing Cash Flow | 2.03 Million | -12.49 Million | -9.62 Million | -681 Thousand | -9.82 Million | 3.11 Million |
| Investments in PPE | -1.2 Million | -6.61 Million | -9.62 Million | -721 Thousand | -162 Thousand | -1.41 Million |
| Acquisitions | -4.88 Million | - | - | - | 85 Thousand | 118 Thousand |
| Investment purchases | - | - | - | - | -9.8 Million | -175 Thousand |
| Sales/Maturities of investments | - | - | - | 40 Thousand | 51 Thousand | 57 Thousand |
| Other Investing Activities | -1.05 Million | -5.88 Million | -50 Thousand | -195 Thousand | -499 Thousand | 4.52 Million |
| Financing Cash Flow | -6.5 Million | -2.29 Million | -1.8 Million | -1.69 Million | -208 Thousand | - |
| Debt repayment | -1.32 Million | -2.29 Million | -1.8 Million | -1.69 Million | -208 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -4.88 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5.18 Million | -2.38 Million | -1.93 Million | -1.9 Million | -241 Thousand | - |
| Accounts receivables | 3.13 Million | 1 Million | 3.18 Million | 823 Thousand | 8.33 Million | 3.16 Million |
| Accounts payables | -1.83 Million | 178 Thousand | -236 Thousand | 453 Thousand | -1.88 Million | 1.2 Million |
| Inventory | -4.13 Million | 4.88 Million | -630 Thousand | -1.63 Million | -279 Thousand | -1.68 Million |
| Other working capital | -3.64 Million | -2.73 Million | -139 Thousand | 1.43 Million | -20.14 Million | -1.2 Million |
| Cash at beginning of period | 102.4 Million | 133.61 Million | 148.39 Million | 147.93 Million | 169.89 Million | 161.76 Million |
| Cash at end of period | 93.61 Million | 122.2 Million | 133.61 Million | 148.39 Million | 147.93 Million | 148.9 Million |
| Capital Expenditure | -1.2 Million | -6.61 Million | -9.62 Million | -721 Thousand | -162 Thousand | -1.41 Million |
| Effect of forex changes on cash | -635 Thousand | 163 Thousand | -1.75 Million | 3.07 Million | -1.67 Million | -888 Thousand |
| Net cash flow / Change in cash | -8.79 Million | -11.41 Million | -14.77 Million | 468 Thousand | -21.96 Million | -12.86 Million |
| Free Cash Flow | -4.89 Million | -3.4 Million | -11.22 Million | -953 Thousand | -10.42 Million | -16.5 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -159.5 Million | 74.77 Million | -237.72 Million | 129.26 Million | 83.44 Million | 45.82 Million |
| Depreciation & Amortization | 9.04 Million | 4.52 Million | 4.45 Million | 8.66 Million | 4.5 Million | 4.15 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6.47 Million | -5.73 Million | - | 3.32 Million | 2.36 Million | - |
| Other non-cash items | 13.01 Million | -70.87 Million | 237.75 Million | -138.04 Million | -72.27 Million | -45.1 Million |
| Investing Cash Flow | 2.03 Million | 6.46 Million | -882 Thousand | -12.49 Million | -6.38 Million | -6.11 Million |
| Investments in PPE | -1.2 Million | -1.2 Million | - | -6.61 Million | -6.61 Million | - |
| Acquisitions | -4.88 Million | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.05 Million | 7.66 Million | -4.42 Million | -5.88 Million | 4.29 Million | -6.11 Million |
| Financing Cash Flow | -6.5 Million | -5.62 Million | -6.38 Million | -2.29 Million | -1.3 Million | -989 Thousand |
| Debt repayment | -1.32 Million | - | - | -2.29 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -4.88 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5.18 Million | -5.62 Million | -882 Thousand | -2.38 Million | -1.39 Million | -989 Thousand |
| Accounts receivables | 3.13 Million | 1.36 Million | - | 1 Million | 1 Million | - |
| Accounts payables | -1.83 Million | - | - | 178 Thousand | - | - |
| Inventory | -4.13 Million | -4.13 Million | - | 4.88 Million | 4.88 Million | - |
| Other working capital | -3.64 Million | -2.96 Million | - | -2.73 Million | -3.52 Million | - |
| Cash at beginning of period | 102.4 Million | 89.78 Million | 122.2 Million | 133.61 Million | 120.66 Million | 133.61 Million |
| Cash at end of period | 93.61 Million | 114.46 Million | 110.06 Million | 122.2 Million | 122.2 Million | 120.66 Million |
| Capital Expenditure | -1.2 Million | -1.2 Million | - | -6.61 Million | -6.61 Million | - |
| Effect of forex changes on cash | -635 Thousand | 292 Thousand | -927 Thousand | 163 Thousand | 2.63 Million | -2.47 Million |
| Net cash flow / Change in cash | -8.79 Million | 24.68 Million | -12.14 Million | -11.41 Million | 1.53 Million | -12.95 Million |
| Free Cash Flow | -4.89 Million | 1.48 Million | -4.42 Million | -3.4 Million | 44 Thousand | -3.44 Million |
ROBU
UFI
SWG
PROC
2201
DCOHF